Table of Contents
Advances in Epidemiology
Volume 2014, Article ID 230587, 6 pages
http://dx.doi.org/10.1155/2014/230587
Research Article

Isoniazid Preventive Therapy Adherence and Associated Factors among HIV Positive Patients in Addis Ababa, Ethiopia

1Research and Training Department, Yeroam Consultancy, P.O. Box 50332, Addis Ababa, Ethiopia
2Addis Continental Institute of Public Health, P.O. Box 26751, Addis Ababa, Ethiopia
3Department of Public Health, College of Health and Medical Sciences, Haramaya University, P.O. Box 235, Harar, Ethiopia

Received 9 April 2014; Revised 29 June 2014; Accepted 9 July 2014; Published 22 July 2014

Academic Editor: Toru Mori

Copyright © 2014 Melaku Berhe et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. WHO and USAID, Core Epidemiology Slides, Global Summary of the AIDS Epidemic 2012, 2013.
  2. WHO, Guide Lines for Implementing Collaborative TB and HIV Programme Activities, World Health Organization, Geneva, Switzerland, 2003.
  3. UNAIDS, “Global report on the global AIDS epidemic,” 2013.
  4. Federal Democratic Republic of Ethiopia and Federal HIV/AIDS Prevention and Control Office, “Report on Progress Towards Implementation of The UN Declaration of Commitment on HIV/AIDS,” Addis Ababa, Ethiopia, 2010.
  5. Federal Minstry of Health & Federal HIV/AIDS Prevention and Control Office, Single Point HIV Prevalence Estimate, Addis Ababa, Ethiopia, 2007.
  6. Federal Ministry of Health, Tuberculosis, Leprosy and TB/HIV Prevention and Control Programme Manual, Federal Ministry of Health, Addis Ababa, Ethiopia, 4th edition, 2008.
  7. Federal Minstry of Health, TB/HIV and Leprosy Prevention and Control Strategic Plan, Federal Minstry of Health, Addis Ababa, Ethiopia, 2007–2009.
  8. WHO, TB/HIV Clinical Manual, 2004.
  9. WHO, Three I's Meeting, World Health Organization, Geneva, Switzerland, 2008.
  10. L. Martin, S. Williams, and R. Dimatto, “The challenge of patient adherence,” The Clinical Risk Management, vol. 1, no. 3, pp. 189–199, 2005. View at Google Scholar
  11. E. Vermeire, H. Hearnshaw, P. van Royen, and J. Denekens, “Patient adherence to treatment: three decades of research: a comprehensive review,” Journal of Clinical Pharmacy and Therapeutics, vol. 26, no. 5, pp. 331–342, 2001. View at Publisher · View at Google Scholar · View at Scopus
  12. International AIDS Society—USA, “Tuberculosis and HIV in the Caribbean: approaches to diagnosis, treatment, and prophylaxis,” Topics in HIV Medicine, vol. 12, no. 5, pp. 144–149, 2004. View at Google Scholar
  13. WHO, Interim Policy on Collaborative TB/HIV Activities, Geneva, Switzerland, 2004.
  14. M. G. Amuha, P. Kutyabami, F. E. Kitutu, R. Odoi-Adome, and J. N. Kalyango, “Non-adherence to anti-TB drugs among TB/HIV co-infected patients in Mbarara Hospital Uganda: prevalence and associated factors,” African Health Sciences, vol. 9, supplement 1, pp. S8–S15, 2009. View at Google Scholar · View at Scopus
  15. M. Mindachew, A. Deribew, F. Tessema, and S. Biadgilign, “Predictors of adherence to isoniazid preventive therapy among hiv positive adults in Addis Ababa, Ethiopia,” BMC Public Health, vol. 11, article 916, 2011. View at Publisher · View at Google Scholar · View at Scopus
  16. Addis Ababa City Adminstration Health Bureau, Operational Manual for Regional HIV/AIDS Care and Treatment Catchments Team Activities, Addis Ababa City Adminstration Health Bureau, Addis Ababa, Ethiopia, 2010.
  17. D. A. Mitchison, “How drug resistance emerges as a result of poor compliance during short course chemotherapy for tuberculosis,” International Journal of Tuberculosis and Lung Disease, vol. 2, no. 1, pp. 10–15, 1998. View at Google Scholar · View at Scopus
  18. T. A. Szakacs, D. Wilson, D. W. Cameron et al., “Adherence with isoniazid for prevention of tuberculosis among HIV-infected adults in South Africa,” BMC Infectious Diseases, vol. 6, article 97, 2006. View at Publisher · View at Google Scholar · View at Scopus
  19. D. Taddesse, Assesement of IPT Implementation, Adherence and its Determinats in the Public Health Facilities of Diredawa UOG/ACIPH, 2009.
  20. B. S. Sutton, M. S. Arias, P. Chheng, M. T. Eang, and M. E. Kimerling, “The cost of intensified case finding and isoniazid preventive therapy for HIV-infected patients in Battambang, Cambodia,” International Journal of Tuberculosis and Lung Disease, vol. 13, no. 6, pp. 713–718, 2009. View at Google Scholar · View at Scopus
  21. T. Aisu, M. C. Raviglione, E. van Praag et al., “Preventive chemotherapy for HIV-associated tuberculosis in Uganda: an operational assessment at a voluntary counselling and testing centre,” AIDS, vol. 9, no. 3, pp. 267–273, 1995. View at Publisher · View at Google Scholar · View at Scopus
  22. M. L. Garcia, J. L. Valdespino, C. Garcia-Sancho et al., “Compliance and side effects to chemoprophylaxis for TB in HIV+ Mexican experience,” in Proceedings of the International Conference on AIDS, 9 (324), abstract no. PO-B07-1133, 1993.
  23. J. Ngamvithayapong, W. Uthaivoravit, H. Yanai, P. Akarasewi, and P. Sawanpanyalert, “Adherence to tuberculosis preventive therapy among HIV-infected persons in Chiang Rai, Thailand,” AIDS, vol. 11, no. 1, pp. 107–112, 1997. View at Publisher · View at Google Scholar · View at Scopus
  24. M. Bakari, A. Moshi, E. A. Aris et al., “Isoniazid prophylaxis for tuberculosis prevention among HIV infected police officers in Daresalaam,” East African Medical Journal, vol. 77, no. 9, pp. 494–496, 2000. View at Google Scholar · View at Scopus
  25. R. L. Ailinger, J. B. Moore, N. Nguyen, and H. Lasus, “Adherence to latent tuberculosis infection therapy among latino immigrants,” Public Health Nursing, vol. 23, no. 4, pp. 307–313, 2006. View at Publisher · View at Google Scholar · View at Scopus
  26. P. J. Munseri, E. A. Talbot, L. Mtei, and C. F. Von Reyn, “Completion of isoniazid preventive therapy among HIV-infected patients in Tanzania,” International Journal of Tuberculosis and Lung Disease, vol. 12, no. 9, pp. 1037–1041, 2008. View at Google Scholar · View at Scopus